[PA6 Daily Review] Raw Material Costs Support, Local Slicing Slightly Increases

Today's Summary

Today, China’s domestic PA6 chip market was generally stable, with slight price increases for some grades, while the cost side became the key support for the market. Earlier, Sinopec refineries in multiple regions raised their ex-works benzene prices, driving up prices along the feedstock chain. This week, Sinopec’s weekly settlement price for caprolactam was finalized at RMB 11,310/mt, with a strong price-supportive sentiment on the raw material side. Some polymerization plants raised their ex-works offers for chips, and downstream buyers made limited purchases to meet essential needs, leading to a slight improvement in market transactions compared with the previous period. Overall industry operating rates remained moderate, while producers were generally operating at a loss.

2. Spot Overview

In terms of spot prices, the majority of PA6 chip prices in East China remain stable, with ordinary high-speed spinning chips seeing a slight increase of 100 yuan/ton. The mainstream price for regular spinning ordinary chips is 11,400-11,500 yuan/ton (cash short delivery); high-end regular spinning is 11,400-11,600 yuan/ton (cash self-pickup); ordinary high-speed spinning chips are at 11,400-11,500 yuan/ton, up by 100 yuan/ton, while premium high-speed spinning chips remain at 11,400-11,600 yuan/ton (accepted delivery). The upstream caprolactam spot market in East China is operating steadily, with a mainstream price of 11,000 yuan/ton for accepted delivery.

In terms of market trading, upstream pure benzene and caprolactam have continued to maintain their prices, leading to increased cost pressure for polymer factories, prompting some manufacturers to actively raise their ex-factory prices for chips. Downstream terminal industries are purchasing as needed, with a small amount of low-level inventory replenishment driving a slight improvement in market transactions; overall, there is no large-scale concentrated stocking action, and most downstream manufacturers are cautiously observing the market, with transactions primarily based on small to medium-sized orders driven by essential needs.

3. Production Dynamics

The domestic PA6 industry is operating smoothly, with no large-scale plant turnarounds currently being implemented. The industry’s overall capacity utilization rate stands at 62.83%, indicating a moderate operating level. Profitability across the industry remains weak, with all product segments operating at a loss: standard spinning chip production is losing RMB 600 per ton, while high-speed spinning chip losses have widened to RMB 680 per ton. Some polymerization enterprises already have maintenance plans in place, and the supply of low-priced cargo in the market may gradually tighten in the future.

4. Market Sentiment

There is a divergence in bullish and bearish sentiment along the industrial chain. Upstream raw material suppliers and polymerization plants are facing relatively high cost pressure, and are generally supporting prices and holding back sales; downstream weaving manufacturers remain highly cautious and resistant to high-priced supply, only maintaining just-in-time replenishment. Middlemen are trading according to market conditions, balancing shifts on both the cost and demand sides. Overall market sentiment is mildly bullish, with no strong expectation of one-sided trading.

5. Market Forecasting

In the short term, China’s domestic PA6 chip market is expected to fluctuate with a firm bias, with room for a continued modest increase. The key bullish support comes from strong caprolactam feedstock prices, which provide a solid cost floor. Polymerization plants are under cost pressure, while expectations of upcoming unit maintenance are likely to tighten the supply of low-priced cargoes. On the demand side, a gradual recovery in rigid demand will further support the market. Overall, the market is driven by both costs and rigid demand, and PA6 chips are expected to maintain a narrow-range upward trend in the short term.

(The above analysis is based on publicly available market data and is for reference only. It does not constitute investment advice.)